1416TiP CodeBreak 200: A phase III multicenter study of sotorasib (AMG 510), a KRAS(G12C) inhibitor, versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC) harboring KRAS p.G12C mutation

Guardat en:

Dades bibliogràfiques
Autors principals:	Martin Reck, Alexander I. Spira, Benjamin Besse, Jennifer Moriatis Wolf, Ferdinandos Skoulidis, Hossein Borghaei, Kōichi Goto, K. Park, Frank Griesinger, Enriqueta Felip, Michael Boyer, Carlos H. Barrios, Glenwood Goss, Hui Yang, Cynthia Obiozor, Suresh S. Ramalingam
Format:	Artigo
Idioma:	anglès
Publicat:	2020
Accés en línia:	https://doi.org/10.1016/j.annonc.2020.08.1730 http://www.annalsofoncology.org/article/S0923753420417260/pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Internet